USA Manufactured, highly accurate, rapid COVID-19 Antibody test. Clinically validated in the USA by Harvard and UCSF Universities, and found to be best-in-class of Antibody tests. 95-100% accuracy in identifying patients after days 12. Manufacturer has a decade of experience in rapid testing. Available in either bulk or home-use packaging. Manufcatured and ships out of Miami, Florida.
[CONTENTS] (25) Test Kits (25) Individual Test Kits (25) Serum Pipets (1) Instruction For Use SENSITIVITY 100% | SPECIFICITY 97.3%
Rapid Antibody kit used for testing to detect the neutralized Antibodies in Patrons.
AbChek (SARS-CoV-2) IGM/IGG Corona Rapid Antibody Test Kit Product Details: Number of Reactions(Preps)/Kit : 50 Brand : AbChek ICMR(Govt) Approved : Yes Test Method : (SARS-CoV-2) IgM/IgG Rapid Antibody Result Time (Rapid Kits) : 5-10 minutes Sample Type : Blood Type : Rapid Test Kit Sensitivity : 98 Packaging Size : 50 Tests/ Box Country of Origin : Made in India Corona viruses are enveloped RNA viruses that are distributed broadly among humans, birds and other mammals, that cause respiratory, enteric, hepatic, and neurologic disease. SPECIFICATIONS: Whole blood/serum/plasma may be used for testing. Results available in only 15 minutes. Easy to use. Result can be read visually. No need for an analyser. Cost effective method for assisting in screening COVID-19 disease. Additional Information: Item Code: RapidTestcov19 Production Capacity: 100000 Delivery Time: 10 days Packaging Details: Carton Box
Covi-G (powered by Cipla) Rapid Test kit combines quality, efficacy and convenience - offering precise results in 10-15 mins Features & Benefits Covid IgM-IgG Serologic Rapid Test for COVID-19 is used to qualitatively detect IgG and IgM antibodies against SARS-CoV-2 in whole blood in vitro Precise and effective - Tests for both IgM and IgG antibodies - Sensitivity and specificity comparable to highest available offerings Sensitivity: IgG 92%, IgM 82%; Specificity IgG 97%, IgM 94% - ->92% total accuracy: IgG 96,5% - IgM: 92,8% - High reproducibility (consistent results across the same patient) - High quality, reliable & convenient - Single-prick blood test - 10-15 minutes per test - Intuitive visual interpretation - No specialized training or equipment needed - Portable hence highly scalable - Storage at room temperature (2-30 C) - Conformance to CE (Europe) and ISO manufacturing The Covi-G platform for Rapid Antibody tests has a set of unique and unparalleled offerings SUSTAINABLE QUALITY Validated Declaration of CE conformity - Launched in Feb 2020, among the earliest technologies/ kits to declare CE-compliance, and continuing strong compared to competitors - Under process for receiving USDA E authorization Among only 3 integrated vendors of Rapid tests Developed and manufactured in Europe (Belgium) - One of the very lew players manufacturing in Europe, with zero complaints also certified locations ACCEPTABILITY ACROSS MARKETS Demonstrated capabilities in local countries validation - Independent local studies conducted in Belgium and France, validating the sensitivity and specificity of the product Participated in published research - Covl-G kit compared lavorably with 7 lgFL IgM rapid antibody tests and IgG ELISA in a comparative study published by Elsevier Science Direct, verifying sensitivity of the kit PROVEN COMMERCIAL EXPERIENCE Sold in 25+ countries already - Including Europe, US, Canada, Africa and multiple developed and emerging markets - Under participation in govt tenders Robust manufacturing capability and capacity - ISO-certified manufacturing site - Ability to cater to high manufacturing volumes from Belgium, to ensure adequale QA and commercial viability AFFORDABLE AND SCALABLE Viable to scale up at Institutions and Retail level - Economical cost per-unit established over many months of process improvement and local manufacturing - Can cater to insured as well as out-of pocket populations Continuous improvement through R&D - Multiple rounds of performance testing complete, further testing in 5 reputed hospitals underway in Belgium, France, USA and Canada - Other platforms including Rapid antigen testing also being developed The price is per unit, the minimum is 25000 units
Assay+ Syphilis ntibody rapid test is manufactured in Canada to detect specific syphilis IgG for the healthcare providers. Assay+ syphilis Rapid Test Kit is qualitative test device for syphilis antibodies from human serum or plasma,. This device has been OEM over one million for our customers. Sensitivity over 95% syphilis infected patients, and 100% specificity have been proved used by our customers in large quantity.
Antibody rapid test kits: Our test kits are superior in sensitivity and specificity. All have CE and FDA registration. Now we are able to offer these same goods and services to your establishment. Delivery 14 days. If you are interested, please do not hesitate to contact us. Thank you for your kind attention. Best regards. Chaveng Munchantip (George) Director (Medical Supplies)
Antibody rapid test kits: Our test kits are also superior in sensitivity and specificity. All have CE and FDA registration. Now we are able to offer these same goods and services to your establishment. Delivery 14 days. If you are interested, please do not hesitate to contact us. Thank you for your kind attention. Best regards. Chaveng Munchantip (George) Director (Medical Supplies)
HCV Rapid Test Antibodies (Uncut Sheet) Specimen: Whole Blood/Serum/Plasma Format:2.5mm 3.0mm 4.0mm Accuracy:99.6% Cut-off:2nCU/mL Sensitivity:99.8% Specificity:99.5% Package: in bulk or unit box package for your options Delivery date:7-10 days after receipt of the payment Pouch design: white pouch / netrual/ OEM design/CE Marked Payment:Westren Union,T/T
Product Description : Solid phase immunochromatographic test kit for the rapid and differentiated detection of IgG and IgM antibodies in blood, plasma or blood serum. Price of product ( USD price or FOB price) : USD 14,68 Product origin : China Key Specifications/Special Features : Test Kit: Blood / serum / plasma Minimum Order Size and Packaging details : Packing 1, 5, 10 , 25 units, Minimum Order Quantity
COVID-19 IgG/IgM Rapid Antibody Test Kit with EUA FDA approval. Available immediately! (Whole Blood/Serum/Plasma) is a solid phase immuno chromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma. - Fast results as soon as 2-10 minutes - Facilitates patient treatment decisions quickly - Simple, time-saving procedure - Little specimens, only 5L of serum/plasma or 10L of whole blood specimens - All necessary reagents provided & no equipment needed - High sensitivity and specificity - Sensitivity: IgG 97.2%; IgM 87.9% - Specificity: IgG 100%; IgM 100% - Specimen: Whole Blood, Serum, Plasma - Shelf Life: 24 months from the date of manufacture
We would like to offer you our PPE Product of Rapid Antigen and Antibody Test Kit as follows: Certification: Full CE and Free sales certification in UAE and SAUDI ARABIA. Country of Origin: China FOB Price: $2.17 USD / Piece (25 Piece / Box) Order Quantity: 100,000 Pieces Production Capacity: 20M Pieces / Month. Delivery: 1st Delivery after 30 days confirmed advance deposit payment Payment Terms: Advance Deposit Payment T/T 50% in advance by Bank Transfer after mutual SPA Contract is signed against T/T 50% Remaining Balance after SGS FRI and L/S Inspection before shipment. We hope to have a long-term business relationship with your esteemed company. Please advise us your email address to enable us to send our quotation by email. Thank you and waiting to read from you as soon as possible.
Tb(tuberculosis) rapid test antibodies (uncut sheet) Specimen: whole blood/serum/plasma Format:2.5mm 3.0mm 4.0mm Accuracy:99.6% Sensitivity:100% Specificity:98.2% Package: in bulk or unit box package for your options Delivery date:7-10 days after receipt of the payment Pouch design: white pouch / netrual/ oem design/ce marked Payment:westren union, t/t
This rapid test kit is to detect p80 protein specific antibody of bvdv, which is accurate, sensitive and specific.
Covid 19 Rapid Antibody Test Kits IgG IgM Brand HEALGEN 98% Accurate 10 Minute Response
TBG SARS-CoV-2 Neutralizing Antibody Qualitative Rapid Test(colloidal gold) Now with the detection before and after vaccination, TBG''s company has a neutralizing antibody detection reagent, that it can be used as the effective rate detection of antibody before and after vaccination. No matter how the vaccine is administered, The Neutralizing Antibody Qualitative Rapid Test will be used. Our test kits for COVID-19 as below are still effective to detect the infection of new COVID-19 variant B.1.1.7and The new variant has no effect on the detection performance of products
The product is based on the principle of antigen-antibody reaction and immunoassay technique. The test device contains colloidal gold labeled SARS-CoV-2 recombinant protein, mouse-anti human IgG antibody immobilized in G test area, mouse-anti human IgM antibody immobilized in M test area and the corresponding antibody in quality control area (C). During the test, when the SARS-CoV-2 IgM antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgM antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. The conjugates migrate upward through capillary effect and would be captured by mouse-anti human IgM antibody immobilized in M test area subsequently and this produces a purple-red band appears in the M test area. When the SARS-CoV-2 IgG antibody level in the sample is at or above the limit of detection of the test, the SARS-CoV-2 IgG antibody in the sample binds to the colloidal gold labeled SARS-CoV-2 recombinant protein which is pre-coated on a gold label pad. Theconjugates migrate upward through capillary effect and would be captured by mouse-anti human IgG antibody immobilized in G test area subsequently and this produces a purple-red band appears in the G test area. If it is a negative sample, there is not a purple-red band appeared in the M and G test area. Regardless of the presence or absence of the SARS-CoV-2 antibody in the sample, a purple-red band will appear in the quality control area (C). The purple-red band in the quality control area (C) is a criterion for judging whether there is enough sample and whether the chromatography process is normal. It also serves as the internal control standard for reagents.
The PocRoc SARS-CoV-2 Neutralizing Antibody Rapid Test Kit is developed for in vitro qualitative detection of SARS-CoV-2 neutralizing antibodies in human serum, plasma, or whole blood samples. SARS-CoV-2 Neutralizing antibody is an important marker for assessing the effectiveness of the SARS-CoV-2 vaccines. The reagent is for neutralizing antibody detection in samples from individuals after vaccine injection or recovered from COVID-19. PocRoc�® SARS-CoV-2 Neutralizing Antibody Rapid Test Kit has great significance for the development of SARS-CoV-2 vaccines, evaluation of effectiveness, and evaluation of neutralizing antibody levels in human bodies. For Medical Professional Use Only! TEST PROCEDURE Do not open the sealing strip until you are ready to perform a test, and the single-use test is suggested to be used under a low environment humidity (RHâ?¤70%) within 1 hour. 1. Allow all the components of the kit and specimens to reach room temperature prior to testing. 2. Take out the test card and place it on a clean dry surface. 3. Identify the test card for each specimen. 4. Use a dropper to deliver one drop (~40�¼l) of serum, plasma, or whole blood samples into the sample well on the test card, followed by one drop (~40l) of sample buffer. 5. Start the timer and read the result immediately after 15 minutes, and the result after 30 minutes is invalid.
PANODYNE - The new rapid lgM-lgG combined antibody test* for COVID-19 from Multibrands International is now available to test for the detection of lgG and lgM antibodies of coronavirus from a small specimen of human serum, plasma or whole blood. The detection works with proteins to indicate if a person's immune system has responded with the COVID-19 virus to indicate infection.
The COVID-19 IgG/IgM (Whole Blood/Serum/Plasma) Rapid Test Device utilizes lateral flow technology that is used for the qualitative, differential detection of both anti-SARS-CoV-2 IgM and IgG antibodies. In general, antibodies can be detected 1-3 weeks after infection. This test is intended to screen patients for COVID-19. Combining RNA and Antibody tests can significantly raise the sensitivity for detecting COVID-19 in infected individuals. This test has been authorized by the FDA under a EUA for professional use CLIA and CLIA WAIVED for Point Of Care. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. This product is intended for professional use and not for home use. FACT SHEET FOR HEALTHCARE PROVIDERS This test has been authorized by the FDA under a EUA for use by authorized CLIA laboratories. This device is CLIA waived for point of care use for fingerstick whole blood specimens only. The user should be trained in the procedure. Wear appropriate protective attire for your safety when handling patient samples. This test has been authorized only for the presence of IgM and IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens. There should be a blue line in the control region (next to ) before testing, discard the device if there is no blue line.
